Chen et al. [122] reported that overexpression of Cdc42 is widespread in patients with primary lung cancer, and that the expression level of Cdc42 can be utilized as a prognostic marker for NSCLC metastasis. The gene discussed is CDC42; the disease is non-small cell lung carcinoma.